Investigation on Medical Management of Dry Eye Patients
NCT ID: NCT01942226
Last Updated: 2013-12-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
466 participants
OBSERVATIONAL
2013-08-31
2013-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Clinical diagnosis of dry eye syndrome
* Have at least one Schirmer's test positive result (less than 10mm/5min) in at least one eye within one year
Exclusion Criteria
* Cognitive or psychiatric deficit that precludes informed consent
* Cognitive or psychiatric deficit that precludes ability to perform requirements of the investigation
20 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Taiwan University Hospital
OTHER
Sun-Huei Tseng Eye Institute
UNKNOWN
Institute of Clinical Pharmacy and Pharmaceutical Sciences, National Cheng Kung University, Tainan, Taiwan
UNKNOWN
Allergan Pharmaceuticals Taiwan Co., Ltd.
INDUSTRY
National Cheng Kung University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yea-Huei Kao Yang
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yea-Huei Kao Yang, Professor
Role: PRINCIPAL_INVESTIGATOR
Institute of Clinical Pharmacy and Pharmaceutical Sciences, National Cheng Kung University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sun-Huei Tseng Eye Institute
Tainan City, , Taiwan
Department of Ophthalmology, National Taiwan University Hospital
Taipei, , Taiwan
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Yeh PT, Chien HC, Ng K, Tseng SH, Chen WL, Hou YC, Wang IJ, Chu HS, Kao Yang YH, Hu FR. Concordance between patient and clinician assessment of dry eye severity and treatment response in Taiwan. Cornea. 2015 May;34(5):500-5. doi: 10.1097/ICO.0000000000000409.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MODE
Identifier Type: -
Identifier Source: org_study_id